Location:
2009 OSU College of Pharmacy Annual Rising Fund Lecture, Salishan Lodge, Oregon Coast
Name:
Michael Deininger, MD, Ph.D., The Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University
Keynote Lecture: Tyrosine kinase inhibitor therapy for cancer: From fiction to fact
Host:
OSU College of Pharmacy, Department of Pharmaceutical Sciences
